GRACE :: Lung Cancer
Denise Brock

ASCO 2016 – Highlights and New Approaches In Lung Cancer and Treating Head and Neck Cancer

Share

(photo: ASCO/Todd Buchanan 2016)

 

 GRACE is happy to present roundtable discussions highlighting news from ASCO 2016

Direct from ASCO 2016: Highlights and New Approaches in Lung Cancer

News from ASCO 2016: Treating Head and Neck Cancer

     
 
 

Highlights and New Approaches in Lung Cancer

 

Treating Head and Neck Cancer

 
 
 
ASCO 2016 – Rova-T Shows Promise in Small Cell Lung Cancer- 4:54 
 
   

 
ASCO 2016 – Can Online Patient Groups Speed the Development of New Targeted Therapies? – 4:33
 
 

 
ASCO 2016 – Urine or Blood Testing Instead of Lung Biopsy Shows Promise for Finding EGFR Mutations – 8:29
 
 

 
ASCO 2016 – Local Consolidation Therapies for Oligometastases – 12:30
 
 
 

 
ASCO 2016 – J-Alex Trial: Should Alecensa Replace Xalcori as First Line ALK Therapy? – 11:01
 
 

 

ASCO 2016 – Does Current Evidence Support Favoring Proton-Beam Radiation? – 8:35

 


 

ASCO 2016 – Immuno-oncology Developments – Combinations and Use as First-Line Therapy – 7:11

 


 

ASCO 2016 – Promising Early Results for Treatments Targeting New Mutations – 4:58

 

 


 

 ASCO 2016 – New Trials of Targeted Therapies to Treat Leptomeningeal Carcinomatosis – 4:31

 
 

 GRACE would like to thank the following companies for their support of this program

 
 
 
 
ASCO 2016 – The Immune System and PD-1 Inhibitors – 1:45
 
 

 

ASCO 2016 – How Promising Are the Results from Checkmate 141? – 2:58

 

 


 

ASCO 2016 – Data from Keynote 12: Nivolumab and Pembrolizumab – 4:11

 

 


 

ASCO 2016 – Common Side Effects of PD-1 Inhibitors – 4:16

 

 


 

ASCO 2016 – Using Biomarkers in Immunotherapy – 2:03

 

 


 

ASCO 2016 – Keynote 55: Pembrolizumab for Heavily Pre-Treated Patients – 4:16

 


 

ASCO 2016 – Using Immunotherapy as First-Line Treatment and in Combinations – 4:36

 


 

ASCO 2016 – Promising Early Data for the Oral Inhibitor Buparlisib – 1:54

 

 


 

ASCO 2016 – Are There Less Toxic Alternatives to the “Extreme” Regimen – 4:06

 

 


GRACE would like to thank the following companies for their support of this program